Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14356/2605

Full metadata record

DC Field	Value	Language
dc.contributor.author	Chapagain, Ram Hari	-
dc.date.accessioned	2025-01-02T05:48:14Z	-
dc.date.available	2025-01-02T05:48:14Z	-
dc.date.issued	2024	-
dc.identifier.uri	https://hdl.handle.net/20.500.14356/2605	-
dc.description	Presentation.	en_US
dc.description.abstract	Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal Dr. Ram Hari Chapagain Qualification: MD Pediatrics Chief Consultant Paediatrician: Kanti Children’s Hospital Associate Professor :NAMS Vice President : Nepal Paediatric Society Member : IRC , NAMS Research Involvemnt : Co Investigator : Typhoid Vaccine trial III Co Investigator : Zinc Sepsis Trial III PI : Cholera Vaccine Trial III Contact: chapagainrh2007@gmail.com	en_US
dc.language.iso	en_US	en_US
dc.publisher	24th FERCAP International Conference	en_US
dc.subject	Phase III clinical trial	en_US
dc.subject	Children	en_US
dc.subject	COVID- 19 pandemic	en_US
dc.subject	Clinical research	en_US
dc.subject	Nepal	en_US
dc.title	Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal	en_US
dc.type	Presentation	en_US
Appears in Collections:	DAY II: November 26, 2024; Parallel Sessions 4B: Vulnerability, Informed Consent and Assent Issues: Chairs: Phanthipha Wongwai & Jeevan Bahadur Sherchand, "Hall-B" 08:30-10:30 (Session 4)

Files in This Item:

File	Description	Size	Format
4B-2- Conducting a phase III clinical trial in children during the COVID19 pandemic Experience and lessons learnt from a clinical research facility of Nepal.pdf	Full Presentation.pdf	912.84 kB	Adobe PDF	View/Open